Completed
Lorlatinib Renal Impairment Study
NCT03542305
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
- Locations
-
- Anaheim Clinical Trials, LLC Anaheim, California, United States
- Prism Clinical Research, LLC Saint Paul, Minnesota, United States